Prothelia is a biotechnology firm that develops recombinant human laminin for the treatment of muscular dystrophy. Read more
Merozyne is a top competitor of Prothelia. Merozyne was founded in Lund, Skåne län} in 2015. Merozyne competes in the Biotechnology industry.
Tarix Orphan is Prothelia's #2 competitor. Tarix Orphan is headquartered in Cambridge, Massachusetts, and was founded in 2014. Tarix Orphan competes in the Biotechnology field. Tarix Orphan generates 100% the revenue of Prothelia.
Summit Therapeutics has been one of Prothelia's top competitors. Summit Therapeutics is a Public company that was founded in 2020 in Cambridge, Massachusetts. Like Prothelia, Summit Therapeutics also competes in the Biotechnology industry. Compared to Prothelia, Summit Therapeutics has 35 more employees.
No recent acquisitions found related to Prothelia
No recent funding data found related to Prothelia
No recent investments found related to Prothelia